GlassScriptPhysician profile
William Barnes
NPI 1215985148
$5,377.62
in general payments reported to CMS, 2019-2025
18 companies · $293 in 2025
The $293 reported for 2025 was more than what 75% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,446 · 2020: $1,015 · 2021: $143 · 2022: $507 · 2023: $1,748 · 2024: $226 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,378 · Travel and Lodging: $889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,378.45 |
| Travel and Lodging | $888.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $2,863.78 | 2019-2023 | Esophyx |
| Apollo Endosurgery US INC | $1,277.44 | 2023 | Overstitch Endoscopic Suturing System |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $413.87 | 2023-2025 | Caplyta |
| Ethicon US, LLC | $170.39 | 2023 | Echelon Flex, Echelon; Endopath |
| Medtronic, INC. | $158.13 | 2022 | |
| Olympus America INC. | $132.62 | 2023-2025 | Olympus, 4k Camera Head, Medical Control Unit For Endosurgery Uces-4 |
| Otsuka America Pharmaceutical, INC. | $87.55 | 2023-2025 | Rexulti, Abilify Maintena |
| Lundbeck LLC | $49.73 | 2023-2025 | Rexulti |
| Phathom Pharmaceuticals, INC. | $43.18 | 2025 | Voquezna |
| Micro-Tech Endoscopy USA, INC. | $39.25 | 2025 | Lockado |
| Covidien LP | $29.90 | 2019 | |
| Dexcom, INC. | $18.57 | 2022 | |
| Insulet Corporation | $18.17 | 2025 | Omnipod |
| Boston Scientific Corporation | $17.01 | 2021 | |
| Novo Nordisk INC | $15.98 | 2023 | Rybelsus, Ozempic |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Echosens North America, INC. | $14.18 | 2021 | |
| Melinta Therapeutics, LLC | $14.12 | 2019 | |
| Lucid Diagnostics INC. | $13.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.